Clinical Trial Update: Mechanism of Enhanced Efficacy of Ivonescimab in Neoadjuvant Therapy for Non-Small Cell Lung Cancer

View source ↗

Summary

A clinical trial update exploring the mechanism behind enhanced efficacy of Ivonescimab when used in neoadjuvant therapy for non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Ivonescimab (AK112/SMT112)

Snippet

Sponsor: Peking University People's Hospital | Conditions: Non-Small Cell Lung Cancer, Neoadjuvant Therapy | Status: ACTIVE_NOT_RECRUITING